Monica Koo (University College London, London, UK) discusses an Article in The Lancet Oncology on presenting symptoms of cancer and stage at diagnosis in patients in England.

Rifat Atun (Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA) discusses a Review in The Lancet Oncology on global patterns in public and philanthropic funding for childhood cancer research with Senior Editor Márcia Costa.

Partha Basu (International Agency for Research on Cancer, Lyon, France) discusses a Policy Review in The Lancet Oncology on cervical cancer prevention efforts in India.

David Palma and Anthony Nichols discuss the findings from their ORATOR trial on radiotherapy or robotic surgery for oropharyngeal squamous cell carcinoma.

New Zealand’s new interim Cancer Control Agency director, Diana Sarfati, discusses a series of five papers exploring cancer control in small island nations.

Eric Deutsch (Gustave Roussy Comprehensive Cancer Center, Villejuif, France) presents The Lancet Oncology’s latest series on advances in radioimmunotherapy for cancer.

Georgina Long (The University of Sydney, Sydney, NSW, Australia) discusses three papers from The Lancet Oncology on neoadjuvant approaches for melanoma treatment.

Jens Hillengass discusses the new International Myeloma Working Group consensus guidelines on optimal use of imaging methods for monoclonal plasma cell disorders.

Kee Yuan Ngiam (National University Hospital Singapore, Singapore) discusses a duo of papers exploring big data and machine-learning algorithms for healthcare delivery and pathology in oncology.

CS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India.